Oxford Cannabinoid Technologies, the pharmaceutical company developing cannabinoid-based prescription medicines, has announced plans to list on the London Stock Exchange.
MarketWatch.com - Top Stories, MarketWatch
Tue, 05/18/2021 - 9:48am
Oxford Cannabinoid Technologies, the pharmaceutical company developing cannabinoid-based prescription medicines, has announced plans to list on the London Stock Exchange.